William K. Heiden

2018

In 2018, William K. Heiden earned a total compensation of $5M as President and Chief Executive Officer at AMAG Pharmaceuticals, a 14% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$879,600
Option Awards$1,071,850
Salary$780,635
Stock Awards$2,223,130
Other$11,000
Total$4,966,215

Heiden received $2.2M in stock awards, accounting for 45% of the total pay in 2018.

Heiden also received $879.6K in non-equity incentive plan, $1.1M in option awards, $780.6K in salary and $11K in other compensation.

Rankings

In 2018, William K. Heiden's compensation ranked 2,034th out of 14,244 executives tracked by ExecPay. In other words, Heiden earned more than 85.7% of executives.

ClassificationRankingPercentile
All
2,034
out of 14,244
86th
Division
Manufacturing
731
out of 5,759
87th
Major group
Chemicals And Allied Products
242
out of 2,122
89th
Industry group
Drugs
193
out of 1,811
89th
Industry
Pharmaceutical Preparations
149
out of 1,385
89th

Pay ratio

William K. Heiden's Pay$4,966,215
Median Employee's Pay$195,142
Pay Ratio

25

to 1

In 2018, the annual total compensation of William K. Heiden was $4,966,215.

The annual total compensation of the median employee at AMAG Pharmaceuticals was $195,142.

The ratio of William K. Heiden's pay to the pay of median employee was therefore 25 to one.

Source: SEC filing on April 12, 2019.

Heiden's colleagues

We found five more compensation records of executives who worked with William K. Heiden at AMAG Pharmaceuticals in 2018.

2018

J Butcher

AMAG Pharmaceuticals

Chief Business Officer and Executive Vice President

2018

Julie Krop

AMAG Pharmaceuticals

Chief Medical Officer

2018

Nicholas Grund

AMAG Pharmaceuticals

Former Chief Commercial Officer

2018

Edward Myles

AMAG Pharmaceuticals

Chief Financial Officer

2018

Joseph Vittiglio

AMAG Pharmaceuticals

General Counsel

News

You may also like